As psychedelic drugs gain more support from the medical community as a potential treatment for severe depression, Cornell researchers are making crucial discoveries that explain how compounds such as psilocybin work on the brain.
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to NSE-FAST®, the first rapid blood test designed to aid in the diagnosis of acute ischemic stroke.
A Cornell-led study is challenging a decades-old explanation for how chromosomes exchange genetic material within the biological process that forms eggs and sperm in mammals.
Tree swallows in the northern U.S. and Canada face the greatest risk from climate change despite responding to temperature the same way as tree swallows in the southern U.S.
Expanding broccoli production on the East Coast and outside of California can help stabilize fresh produce supply chains that are vulnerable to water shortages.
A $13.3 million grant from the NIH will support efforts to reveal how immune cells communicate within living tissues, which could shape new approaches for treating inflammatory diseases, autoimmune disorders and infections.
The CCF provides catalytic seed funding to spark pioneering applied research to advance wildlife conservation solutions. The fund prioritizes initiatives that improve the health of free-ranging wildlife and/or solve environmental problems via a One Health lens.
